Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine and Epinephrine for Prevention of Post-ERCP Pancreatitis
ChiCTR-IIR-16007942Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Feb 2016
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of lidocaine and epinephrine in post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) (4 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Incidence of post-ERCP pancreatitis. Started Feb 2016; status: recruiting.
02
Drugs
lidocaineepinephrine
03
Conditions
post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP)
Beyond the preview
Go deeper on ChiCTR-IIR-16007942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-16007942.